Impact of Dipeptidyl Peptidase-4 Inhibitors on Aminotransferases Levels in Patients with Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trial

Impact of Dipeptidyl Peptidase-4 Inhibitors on Aminotransferases Levels in Patients with Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trial

Background: Type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD) are highly prevalent diseases that constitute enormous public health problems. The efficacy of dipeptidyl peptidase-4 (DPP-4) inhibitors in blood glucose control in T2DM patients with NAFLD has been established,...

Full description

Saved in:
Bibliographic Details
Main Authors: Gang Ma, MD, Song Zhang, MD, Baozhong Yu, MD
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Current Therapeutic Research
Subjects:
Aminotransferases
Dipeptidyl peptidase-4 inhibitors
Meta-analysis
Nonalcoholic fatty liver disease
Type 2 diabetes mellitus
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X24000389
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items